OptimizeRx Corp - Common Stock (OPRX)

Q2 2022 13F Holders as of 6/30/2022

Type / Class
Equity / Common Stock
Shares outstanding
18.6M
Number of holders
131
Total 13F shares, excl. options
15M
Shares change
+123K
Total reported value, excl. options
$412M
Value change
-$1M
Put/Call ratio
0.13
Number of buys
78
Number of sells
-56
Price
$27.39

Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q2 2022

168 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q2 2022.
OptimizeRx Corp - Common Stock (OPRX) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15M shares of 18.6M outstanding shares and own 80.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.7M shares), VANGUARD GROUP INC (1.08M shares), BLAIR WILLIAM & CO/IL (781K shares), Artisan Partners Limited Partnership (706K shares), STATE STREET CORP (660K shares), AMERICAN CENTURY COMPANIES INC (616K shares), G2 Investment Partners Management LLC (537K shares), Handelsbanken Fonder AB (516K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (510K shares), and AVENIR CORP (424K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.